Features Alopecia areata steals the spotlight in time for possible treatment paradigm shift News Milltrust Ventures to invest in health tech platform Oncoshot
Comment Investigator-sponsored Phase II/III for Pfizer’s sirolimus for Sturge-Weber Syndrome sees 15-point surge in FDA regulatory potential William Newton
Comment Corbus’ investigator-sponsored Phase II lenabasum trial in SLE has randomised 96 of the targeted 100 patients, investigator says William Newton
Comment Covid-19 Phase III trial of Eiger’s interferon to start pending ongoing $10m financing, primary investigator says Reynald Castañeda
Features Expert Insights: Can FDA Approval of Cimzia for Psoriasis Secure UCB’s Position in the Immuno-dermatology Market? kgi-admin
News Implementing Investigator Site Payment Strategies for Improved Sponsor-Site Relationships kgi-admin
Market Data Avanir reports Phase II data of investigational drug AVP-923 for Alzheimer’s disease admin